Delcath Systems logo
Delcath Systems DCTH
$ 10.83 -1.46%

Annual report 2025
added 02-26-2026

report update icon

Delcath Systems Financial Ratios 2011-2026 | DCTH

Annual Financial Ratios Delcath Systems

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

120.9 -14.2 -1.6 -1.4 -1.9 -2.9 -0.0 -0.4 -0.0 -1.2 - - -187.3 - -

P/S

3.8 10.1 36.2 18.9 13.9 59.9 0.2 2.2 0.0 10.8 - - 7187.8 - -

EPS

0.1 -0.9 -2.9 -4.1 -3.6 -8.3 -342.8 -0.7 -3250 -3707 -0.9 -1.8 -0.3 -0.8 -0.7

EV (Enterprise Value)

295 M 350 M 85 M 67.4 M 47.7 M 53.2 M 10.9 M 26.7 M 4.22 M 53.8 M -5.48 M -14.8 M 5.65 B -13.3 M -16.6 M

EBITDA per Share

0.03 -0.43 -2.34 -3.8 -3.41 -5.59 -700 -698 -54.9 K -49.6 K - - -98.1 K - -

EV/EBITDA

-1.7 -1.7 0.4 -0.3 0.2 -1.9 0.9 1.4 -177.1 0.5 1.8

PEG

-2.37 0.29 0.05 0.03 0.04 -0.03 0.0 -0.0 -0.0 -0.02 - - -2.65 - -

P/B

2.9 5.5 4.7 -8.8 4.1 3.1 -0.1 -0.5 0.0 -14.4 - - 188.7 - -

P/CF

14.5 -20.1 -2.4 -2.1 -2.2 -2.9 -0.0 -0.5 -0.0 -1.5 - - -165.8 - -

ROE %

2.43 -38.38 -302.20 623.11 -214.60 -109.41 139.67 128.67 -6654.42 1206.11 -170.96 -95.79 -100.75 -259.22 -118.35

ROA %

2.18 -34.45 -123.48 -204.39 -77.43 -69.74 -62.48 -280.86 -507.67 -51.00 -93.46 -73.14 -81.74 -170.23 -87.66

ROCE %

0.59 -18.05 -242.01 577.79 -205.25 -98.20 1531.38 248.22 -1692.92 1920.56 -156.08 -90.58 -108.38 -255.39 -117.01

Current Ratio

10.0 9.8 1.7 0.8 1.6 3.2 0.8 0.3 1.0 0.9 2.3 4.8 5.1 2.6 3.6

DSO

48.5 54.6 53.6 27.5 5.2 18.0 12.0 124.7 42.6 73.8 57.9 59.4 161.2 146.0 -

DIO

265.9 302.4 1529.0 907.2 616.6 487.6 332.0 310.4 649.8 438.0 598.1 437.7 565.6 10128.8 -

DPO

56.0 58.2 870.8 706.6 656.0 1011.7 2301.2 2790.9 2002.6 394.2 224.4 938.2 457.8 8577.5 -

Operating Cycle

314.3 357.1 1582.6 934.7 621.8 505.6 344.0 435.1 692.4 511.8 655.9 497.2 726.8 10274.8 -

Cash Conversion Cycle

258.3 298.9 711.8 228.1 -34.2 -506.1 -1957.2 -2355.8 -1310.1 117.6 431.6 -441.1 269.0 1697.2 -

All numbers in USD currency

Quarterly Financial Ratios Delcath Systems

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

0.02 0.08 0.03 - 0.06 -0.48 -0.45 - -1.14 -0.58 -0.77 - -0.96 -1.24 -1.1 - -0.94 -0.96 -1.04 - -1.16 -1.9 -108.07 - -73.82 -58.5 -75.11 - -0.25 -7.26 10.91 -0.75 -4565 -1373 -45695 -1292.02 -230.99 -4.41 -437.5 -0.23 -1.96 -0.3 -0.32 -0.31 -0.48 -0.49 -0.57 -0.04 -0.07 -0.91 -0.15 -0.14 -0.18 -0.26 -0.31 -0.32 -0.18 -0.13 -0.04

EBITDA per Share

-0.01 0.08 0.02 - -0.04 -0.13 -0.41 - -0.59 -0.63 -0.71 - -0.88 -1.15 -1.01 - -0.87 -0.95 -1.03 - -1.13 -1.84 -69.1 - -53.7 -39.5 -53.4 - -0.16 -6.54 -11.2 -20.7 -1.64 K -3.18 K -16.7 K -373 -1.06 K -2.5 -2.32 -3.11 -2.88 -0.28 -0.32 -0.34 -0.51 -0.59 -0.52 -0.66 -1.02 -1.71 -1.85 -0.15 -0.18 -0.27 -0.29 0.33 0.27 0.25 0.17

ROE %

26.37 47.40 -282.96 -382.04 -464.33 -568.36 2735.46 2962.58 3131.79 3383.29 764.21 353.92 293.16 63.18 -336.19 -136.90 -159.51 -121.35 -98.30 -77.57 40.70 181.59 294.69 336.20 395.64 336.80 287.63 55.91 -2782.73 -4699.99 -5031.13 -6654.42 -3246.25 -1321.05 -587.02 1206.04 577.27 481.73 -8.73 -170.96 -127.95 -124.91 -107.25 -95.79 -95.48 -94.30 -87.16 -100.75 -138.09 -173.19 -227.50 -259.24 -264.47 -237.26 -185.64 -118.31 -31.83 -20.91 -7.08

ROA %

10.08 15.30 -27.53 -65.41 -108.17 -156.80 -150.50 -106.38 -150.27 -151.40 -165.42 -125.06 -145.76 -122.57 -100.15 -67.38 -81.79 -75.51 -62.04 -49.45 -102.36 -140.85 -170.44 -150.38 -280.13 -356.97 -412.32 -122.05 -338.61 -350.60 -275.18 -507.67 -315.19 -176.31 -173.36 -50.99 -59.30 -71.84 -76.43 -93.46 -73.47 -77.25 -73.10 -73.14 -73.66 -73.91 -69.33 -81.75 -103.80 -123.14 -155.98 -170.21 -178.57 -163.38 -131.25 -87.64 -23.58 -15.49 -5.24

ROCE %

- - - - - - - - 155.79 311.59 644.90 329.49 272.38 59.48 -316.38 -133.28 -155.84 -121.29 -98.07 -64.87 22.78 132.98 217.24 241.81 280.60 231.73 207.59 129.79 -567.11 -1288.35 -2007.74 -2679.20 -1688.14 -688.64 249.77 1103.36 760.03 400.54 98.62 -160.55 -125.20 -109.04 -98.17 -98.89 -99.96 -95.68 -99.19 -105.13 -148.44 -186.36 -228.16 -267.40 -148.01 -41.43 75.29 177.96 46.66 40.17 29.93

Current Ratio

13.2 9.8 12.3 9.8 1.4 1.1 1.7 1.7 2.1 1.0 1.2 0.8 0.8 0.9 1.2 1.6 1.5 2.5 2.6 2.8 2.8 2.8 2.8 0.7 0.7 0.7 0.7 0.3 0.3 0.3 0.3 1.1 1.1 1.1 1.1 1.0 1.0 1.0 1.0 2.2 2.2 2.2 2.2 4.2 4.2 4.2 3.7 5.3 - 5.3 5.6 - - - - - - - -

DSO

65.7 56.2 57.3 - 43.4 31.1 26.2 - 34.9 53.9 63.0 - 49.1 35.3 26.8 - - - - - - - - - - - - - 64.8 62.2 - - 42.3 49.5 - - - - - - - - - - 73.2 63.3 77.0 - 442.3 - 59.0 - 336.9 124.0 - - - - -

DIO

369.8 242.8 225.6 - 360.5 298.9 351.5 - 1765.7 1465.2 1092.7 - 770.0 1026.8 4732.6 - 494.2 526.3 800.1 - 415.0 464.4 882.7 - 347.0 347.0 718.6 - 336.0 355.9 653.6 - 662.1 843.6 397.5 - 537.7 401.5 582.4 - 767.5 504.2 379.4 - 636.9 482.5 524.0 - 2852.6 197.6 2684.5 - - - - - - - -

DPO

119.1 87.1 41.4 - 117.3 143.2 126.3 - 589.7 1032.3 1120.7 - 912.3 839.0 2600.6 - 484.6 555.2 1225.4 - 861.0 963.6 3689.2 - 2404.9 2404.9 5821.0 - 3021.4 3200.0 3588.2 - 2040.4 2599.6 925.0 - 483.9 361.4 360.9 - 287.9 189.2 354.0 - 1365.1 1034.2 652.5 - 2309.0 160.0 2238.6 - - - - - - - -

Operating Cycle

435.4 299.0 282.8 - 403.9 329.9 377.7 - 1800.5 1519.1 1155.7 - 819.1 1062.1 4759.4 - 494.2 526.3 800.1 - 415.0 464.4 882.7 - 347.0 347.0 718.6 - 400.8 418.1 653.6 - 704.4 893.1 397.5 - 537.7 401.5 582.4 - 767.5 504.2 379.4 - 710.1 545.8 600.9 - 3294.9 197.6 2743.6 - 336.9 124.0 - - - - -

Cash Conversion Cycle

316.4 211.9 241.4 - 286.6 186.8 251.4 - 1210.9 486.8 35.0 - -93.2 223.1 2158.7 - 9.7 -28.9 -425.3 - -446.1 -499.2 -2806.5 - -2057.9 -2057.9 -5102.4 - -2620.6 -2781.9 -2934.6 - -1336.0 -1706.5 -527.5 - 53.8 40.1 221.6 - 479.6 315.1 25.4 - -655.0 -488.4 -51.6 - 985.8 37.7 505.0 - 336.9 124.0 - - - - -

All numbers in USD currency

Multiples are an important financial analysis tool for the company Delcath Systems, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.

Advantages of Using Financial Ratios
  • Simplified Data Analysis
    Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition.
  • Comparability Between Companies
    Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations.
  • Identification of Trends and Issues
    Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks.
  • Decision Support
    Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions.
  • Accelerated Assessment of Investment Attractiveness
    Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.

Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.

Financial Ratios of other stocks in the Medical devices industry

Issuer Price % 24h Market Cap Country
Align Technology Align Technology
ALGN
$ 185.02 -0.81 % $ 13.9 B usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
- - $ 3.31 B usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
- 1.37 % $ 20.5 M usaUSA
Bruker Corporation Bruker Corporation
BRKR
$ 38.94 -1.37 % $ 5.8 K usaUSA
BioSig Technologies BioSig Technologies
BSGM
- 37.08 % $ 85.7 M usaUSA
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
- - $ 1.77 B usaUSA
Acutus Medical Acutus Medical
AFIB
- -26.83 % $ 2.62 M usaUSA
Conformis Conformis
CFMS
- - $ 16.4 M usaUSA
Avinger Avinger
AVGR
- -20.74 % $ 369 K usaUSA
AdaptHealth Corp. AdaptHealth Corp.
AHCO
$ 12.58 -0.55 % $ 1.7 B usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
- 3.58 % $ 2.21 M usaUSA
Lianluo Smart Limited Lianluo Smart Limited
LLIT
- 24.59 % $ 44.8 M chinaChina
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
- -5.86 % $ 30.6 M usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
$ 0.61 3.18 % $ 38 M usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
$ 3.59 1.99 % $ 134 M franceFrance
Boston Scientific Corporation Boston Scientific Corporation
BSX
$ 63.42 -1.83 % $ 93.9 B usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
- - $ 475 M usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
- 0.15 % $ 844 M usaUSA
Eargo Eargo
EAR
- - $ 10.2 M usaUSA
ClearPoint Neuro ClearPoint Neuro
CLPT
$ 10.5 0.38 % $ 297 M usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
- 14.99 % $ 929 K usaUSA
Electromed Electromed
ELMD
$ 25.39 -1.24 % $ 215 M usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
- -0.97 % $ 54.4 M usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
- -4.14 % $ 702 M usaUSA
CHF Solutions, Inc. CHF Solutions, Inc.
CHFS
- 1.15 % $ 34.5 M usaUSA
LENSAR LENSAR
LNSR
$ 5.8 -7.2 % $ 69.4 M usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
- -1.42 % $ 435 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
- -1.98 % $ 98.3 M usaUSA
GBS GBS
GBS
- -0.57 % $ 7.12 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
- 0.03 % $ 1.58 B israelIsrael
Misonix, Inc. Misonix, Inc.
MSON
- - $ 462 M usaUSA
Neovasc Neovasc
NVCN
- - $ 111 M canadaCanada
OrthoPediatrics Corp. OrthoPediatrics Corp.
KIDS
$ 16.53 -7.39 % $ 388 M usaUSA
Globus Medical Globus Medical
GMED
$ 92.76 -1.87 % $ 12.5 B usaUSA
Helius Medical Technologies Helius Medical Technologies
HSDT
$ 2.06 6.19 % $ 1.25 M usaUSA
Butterfly Network Butterfly Network
BFLY
$ 5.29 8.74 % $ 1.12 B usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
- - $ 955 M usaUSA
Inogen Inogen
INGN
$ 6.59 6.29 % $ 175 M usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
$ 1.04 - $ 17.6 M usaUSA
BIOLASE BIOLASE
BIOL
- -13.19 % $ 166 K usaUSA
Inspire Medical Systems Inspire Medical Systems
INSP
$ 56.45 -0.34 % $ 1.66 B usaUSA
CONMED Corporation CONMED Corporation
CNMD
$ 37.91 -3.88 % $ 1.18 B usaUSA
LivaNova PLC LivaNova PLC
LIVN
$ 65.01 -0.2 % $ 3.55 B britainBritain
Integer Holdings Corporation Integer Holdings Corporation
ITGR
$ 88.37 0.49 % $ 3.07 B usaUSA
FONAR Corporation FONAR Corporation
FONR
$ 18.76 -0.05 % $ 123 M usaUSA
Invacare Corporation Invacare Corporation
IVC
- - $ 24.7 M usaUSA
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
EW
$ 79.05 1.09 % $ 46.2 B usaUSA
Sintx Technologies Sintx Technologies
SINT
$ 2.68 -2.19 % $ 7.43 M usaUSA
Penumbra Penumbra
PEN
$ 331.47 -0.29 % $ 12.9 B usaUSA